Home
Reels
Groups
Pages
See More
Groups Pages Events Blogs Offers Jobs Courses Forums Movies Games
Sign In Sign Up
Night Mode
CA 125 Test Market – Emerging Biomarkers and Combination Testing
Market Overview The CA 125 test market is evolving with the emergence of novel biomarkers and combination testing approaches that enhance diagnostic accuracy for ovarian cancer. While CA 125 remains the most widely used biomarker, others such as HE4, ROMA, and OVA1 are increasingly used in combination. The market is projected to grow through 2030, driven by research into multiplex panels,...
0 Comments ·0 Shares ·170 Views ·0 Reviews
Please log in to like, share and comment!